The Nine Therapeutic Extracts in Punch Gunk Muscle & Joint Relief and Their Role in Tendinitis Symptom Relief
Tendinitis is commonly associated with pain, tenderness, stiffness and reduced function around a tendon following repetitive stress, overuse or injury. Although the term traditionally describes tendon inflammation, persistent tendon disorders are increasingly characterized as tendinopathy, a broader condition involving changes in tendon structure, collagen organization and cellular activity in addition to inflammatory signaling. Treatment therefore generally emphasizes appropriate loading, physical rehabilitation and management of pain rather than inflammation alone.
Topical therapies can provide a useful adjunct for managing localized tendon discomfort. This establishes an important principle: locally applied compounds capable of influencing pain or inflammatory pathways may help reduce symptoms even though they do not correct the underlying mechanical cause of tendon injury.
Punch Gunk Muscle & Joint Relief combines nine botanical extracts: aloe, arnica, tea tree, gotu kola, nettle, willow bark, witch hazel, kava and licorice root. These ingredients have different biological properties that could potentially complement one another in managing the symptoms surrounding an irritated tendon.
Arnica (Arnica montana) has perhaps the strongest direct clinical evidence among these botanicals for topical musculoskeletal use. Arnica contains sesquiterpene lactones and other compounds associated with modulation of inflammatory pathways. Clinical research has investigated topical arnica for pain, swelling and inflammatory musculoskeletal conditions. A randomized study involving hand osteoarthritis found an arnica gel produced improvements in pain and function comparable to topical ibuprofen, while systematic reviews conclude that the results across studies are promising but inconsistent and formulation-dependent. For tendinitis, arnica's principal potential role is therefore symptomatic—helping moderate localized soreness and inflammatory discomfort.
Willow bark (Salix species) contains salicin and several polyphenols and flavonoids with analgesic and anti-inflammatory activity. Willow bark has a long history of use for musculoskeletal pain, including tendinitis and bursitis. Clinical studies of orally administered willow bark extracts have demonstrated some pain reduction in musculoskeletal conditions, although evidence remains limited and cannot automatically be extrapolated to topical application. Nevertheless, willow bark provides a biologically plausible complementary component for managing discomfort associated with an overworked tendon.
Gotu kola (Centella asiatica) is particularly relevant to connective-tissue biology. Its triterpenoids—including asiaticoside, madecassoside and asiatic acid—have been studied for their effects on collagen synthesis, fibroblast activity, inflammatory signaling and tissue repair. A 2024 review of topical Centella asiatica research reported evidence that its constituents can modulate inflammation while supporting collagen synthesis and antioxidant protection. A systematic review also found reductions in inflammatory mediators including IL-1β, IL-6, TNF-α, PGE2 and COX-2 in experimental research. These findings are relevant mechanistically because tendons are collagen-rich tissues, but current research does not establish that topical gotu kola repairs human tendons.
Nettle (Urtica dioica) contributes another group of polyphenols and phytochemicals associated with anti-inflammatory and analgesic effects. Reviews describe activity involving several inflammatory pathways, although human clinical evidence remains limited. Its potential value in a tendinitis-oriented topical is therefore primarily supportive: reducing the inflammatory component of localized discomfort rather than modifying tendon pathology itself.
Aloe vera provides both a therapeutic and formulation-support role. Aloe contains polysaccharides and numerous biologically active compounds studied for anti-inflammatory, antioxidant and skin-supporting properties. In a topical preparation, aloe also hydrates and conditions the skin overlying the affected area, which can improve comfort during repeated application.
Licorice root, witch hazel and tea tree provide additional anti-inflammatory, antioxidant, soothing and skin-supporting phytochemicals. Their strongest evidence relates primarily to dermatologic rather than tendon applications. Consequently, their most scientifically supportable contribution is maintaining a comfortable topical environment while complementing the formula's broader anti-inflammatory profile.
Kava (Piper Methysticum) contains kavalactones associated primarily with neurologic and relaxing effects. Evidence for topical kava in human musculoskeletal conditions remains sparse, so claims regarding direct treatment of tendon inflammation should be considered preliminary.
Taken together, Punch Gunk's botanical formulation presents a multi-pathway approach to the symptoms surrounding tendinitis. Arnica and willow bark provide the strongest rationale for localized pain and inflammatory relief; nettle and licorice contribute additional anti-inflammatory phytochemistry; gotu kola introduces compounds associated with collagen biology and tissue-repair signaling; and aloe, witch hazel and tea tree support the skin and local application environment.
Importantly, the available research largely evaluates these botanical ingredients individually and often in conditions other than tendinitis. There are currently insufficient clinical data to conclude that the Punch Gunk formulation itself heals tendon injuries or alters the structural progression of tendinopathy. The scientifically appropriate role is therefore as a topical adjunct for relief of soreness, stiffness and discomfort associated with tendon overuse, alongside appropriate rest, progressive tendon loading, physical therapy and medical evaluation when symptoms persist.
Widrig R, Suter A, Saller R, Melzer J. Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomized, double-blind study. Rheumatology International. 2007;27(6):585–591. doi:10.1007/s00296-007-0304-y.